Massive drug price cuts and KORUS FTA take toll on drug makers

Published: 2011-11-29 07:00:00

Updated: 2011-11-29 07:00:00

The government should work out measures to boost the domestic pharmaceutical industry by lowering generic prices by phase, the Korea Pharmaceutical Manufacturers Association said Monday.

In a statement carried in main daily newspaper on Friday, the KPMA claimed that Korean pharmaceutical compa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK